Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 91 - 100 of 264

Selected Filters:
21 February 2023

Championing Choice in a Multi-product HIV Prevention Market

Recording / Slides / Key Takeaways Individuals who need and want PrEP may soon have multiple options for the first time since oral PrEP was introduced in 2012. New products, including the dapivirine vaginal ring and injectable cabotegravir, have been approved in several countries, and more biomedical prevention products are in development. As the catalog…

Service Delivery

Event
20 February 2023

Clinic-Integrated Smartphone App (JomPrEP) to Improve Uptake of HIV Testing and Pre-exposure Prophylaxis Among Men Who Have Sex With Men in Malaysia: Mixed methods evaluation of usability and acceptability

This article from JMIR mHealth and uHealth describes an evaluation of the smartphone app JomPrEP, which provides a virtual platform for Malaysian men who have sex with men to engage in HIV prevention services.

Research, Service Delivery

External Link
20 February 2023

High PrEP Uptake and Objective Longitudinal Adherence among HIV-exposed Women with Personal or Partner Plans for Pregnancy in Rural Uganda: A cohort study

This article from PLOS Medicine describes the impact of the Healthy Families-PrEP intervention to support PrEP use as part of HIV prevention during periconception and pregnancy periods in Uganda.

Research, Service Delivery

External Link
20 February 2023

Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria

This article from Global Health: Science and Practice describes the impact of the Meeting Targets and Maintaining Epidemic Control (EpiC) project’s comprehensive community-based program to increase access to and uptake of oral PrEP services among people who inject drugs in Bayelsa and Niger States, Nigeria.

Research, Service Delivery

External Link
17 February 2023

New PrEP Product Implementation Roadmap for PrEP vaginal ring and CAB for PrEP in Uganda

This presentation outlines the timelines for implementation of the dapivirine vaginal ring and cabotegravir (CAB) for PrEP in Uganda.

Research, Service Delivery

Document
13 February 2023

Integrating Pre-exposure Prophylaxis of HIV Infection into Family Planning Services: A scoping review

This scoping review from BMJ Sexual and Reproductive Health maps evidence of integrating PrEP into family planning services to identify barriers and enablers of integrating services at the client-level and provider-level.

Research, Service Delivery

External Link
7 February 2023

RISE CAB for PrEP Training Toolkit

With the release of the WHO Guidelines on Long-Acting Injectable Cabotegravir for HIV Prevention in 2022, HIV prevention programs and implementing partners are working to prepare for rapid expansion of additional methods of HIV pre-exposure prophylaxis (PrEP). Experience from the scale-up of previous HIV prevention programs demonstrates the advantages of ready-made provider capacity building resources…

Service Delivery

External Link
30 January 2023

HIV Pre-exposure Prophylaxis (PrEP) Knowledge among General Practitioners in 2020: A French survey

This article from Infectious Diseases Now analyses the knowledge of and position on PrEP amongst general practitioners in Hauts-de-France, France.

Service Delivery

External Link
30 January 2023

An Update on Expanding HIV Preexposure Prophylaxis

This article from the Journal of the American Academy of Physicians Assistants describes how to better employ PrEP in the United States in light of changes to the Centers for Disease Control guidelines on PrEP counselling, monitoring, and delivery, and approval of injectable cabotegravir for PrEP by the US Food and Drug Administration.

Monitoring & Evaluation, Normative Guidance/Policies, Service Delivery

External Link
30 January 2023

Same-day Initiation of Oral Pre-exposure Prophylaxis among Gay, Bisexual, and Other Cisgender Men who Have Sex with Men and Transgender Women in Brazil, Mexico, and Peru (ImPrEP): A prospective, single-arm, open-label, multicentre implementation study

This article from The Lancet HIV assesses the feasibility of same-day oral PrEP delivery amongst gay and bisexual men who have sex with men and transgender women in Brazil, Mexico, and Peru.

Service Delivery

External Link